405 related articles for article (PubMed ID: 36683512)
1. Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfunction: A Hypothesis on a Novel Pathway in the Pathophysiology of Alzheimer's Disease.
Basha SC; Ramaiah MJ; Kosagisharaf JR
J Alzheimers Dis; 2023; 94(s1):S319-S333. PubMed ID: 36683512
[TBL] [Abstract][Full Text] [Related]
2. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
3. Intermittent hypoxia training enhances Aβ endocytosis by plaque associated microglia via VPS35-dependent TREM2 recycling in murine Alzheimer's disease.
Wang X; Xie Y; Fan X; Wu X; Wang D; Zhu L
Alzheimers Res Ther; 2024 Jun; 16(1):121. PubMed ID: 38831312
[TBL] [Abstract][Full Text] [Related]
4. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease.
Ellwanger DC; Wang S; Brioschi S; Shao Z; Green L; Case R; Yoo D; Weishuhn D; Rathanaswami P; Bradley J; Rao S; Cha D; Luan P; Sambashivan S; Gilfillan S; Hasson SA; Foltz IN; van Lookeren Campagne M; Colonna M
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33446504
[TBL] [Abstract][Full Text] [Related]
5. TNF-α-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2
Ren S; Breuillaud L; Yao W; Yin T; Norris KA; Zehntner SP; D'Adamio L
J Biol Chem; 2021; 296():100089. PubMed ID: 33434745
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss.
Popescu AS; Butler CA; Allendorf DH; Piers TM; Mallach A; Roewe J; Reinhardt P; Cinti A; Redaelli L; Boudesco C; Pradier L; Pocock JM; Thornton P; Brown GC
Glia; 2023 Apr; 71(4):974-990. PubMed ID: 36480007
[TBL] [Abstract][Full Text] [Related]
7. SHIP inhibition mediates select TREM2-induced microglial functions.
Ramakrishnan GS; Berry WL; Pacherille A; Kerr WG; Chisholm JD; Pedicone C; Humphrey MB
Mol Immunol; 2024 Jun; 170():35-45. PubMed ID: 38613944
[TBL] [Abstract][Full Text] [Related]
8. TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways.
Wang S; Sudan R; Peng V; Zhou Y; Du S; Yuede CM; Lei T; Hou J; Cai Z; Cella M; Nguyen K; Poliani PL; Beatty WL; Chen Y; Cao S; Lin K; Rodrigues C; Ellebedy AH; Gilfillan S; Brown GD; Holtzman DM; Brioschi S; Colonna M
Cell; 2022 Oct; 185(22):4153-4169.e19. PubMed ID: 36306735
[TBL] [Abstract][Full Text] [Related]
9. The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid-β by microglia.
Huang S; Liao X; Wu J; Zhang X; Li Y; Xiang D; Luo S
FEBS Lett; 2022 Apr; 596(8):1059-1071. PubMed ID: 35292963
[TBL] [Abstract][Full Text] [Related]
10. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model.
Wang Y; Cella M; Mallinson K; Ulrich JD; Young KL; Robinette ML; Gilfillan S; Krishnan GM; Sudhakar S; Zinselmeyer BH; Holtzman DM; Cirrito JR; Colonna M
Cell; 2015 Mar; 160(6):1061-71. PubMed ID: 25728668
[TBL] [Abstract][Full Text] [Related]
11. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
[TBL] [Abstract][Full Text] [Related]
12. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques.
Wang Y; Ulland TK; Ulrich JD; Song W; Tzaferis JA; Hole JT; Yuan P; Mahan TE; Shi Y; Gilfillan S; Cella M; Grutzendler J; DeMattos RB; Cirrito JR; Holtzman DM; Colonna M
J Exp Med; 2016 May; 213(5):667-75. PubMed ID: 27091843
[TBL] [Abstract][Full Text] [Related]
13. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease.
Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T
Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026
[TBL] [Abstract][Full Text] [Related]
14. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
[TBL] [Abstract][Full Text] [Related]
15. TREM2 alters the phagocytic, apoptotic and inflammatory response to Aβ
Akhter R; Shao Y; Formica S; Khrestian M; Bekris LM
Mol Immunol; 2021 Mar; 131():171-179. PubMed ID: 33461764
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
[TBL] [Abstract][Full Text] [Related]
17. TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function.
Zhao Y; Wu X; Li X; Jiang LL; Gui X; Liu Y; Sun Y; Zhu B; Piña-Crespo JC; Zhang M; Zhang N; Chen X; Bu G; An Z; Huang TY; Xu H
Neuron; 2018 Mar; 97(5):1023-1031.e7. PubMed ID: 29518356
[TBL] [Abstract][Full Text] [Related]
18. Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia.
Zhao N; Qiao W; Li F; Ren Y; Zheng J; Martens YA; Wang X; Li L; Liu CC; Chen K; Zhu Y; Ikezu TC; Li Z; Meneses AD; Jin Y; Knight JA; Chen Y; Bastea L; Linares C; Sonustun B; Job L; Smith ML; Xie M; Liu YU; Umpierre AD; Haruwaka K; Quicksall ZS; Storz P; Asmann YW; Wu LJ; Bu G
J Exp Med; 2022 Dec; 219(12):. PubMed ID: 36107206
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2).
Zhong L; Wang Z; Wang D; Wang Z; Martens YA; Wu L; Xu Y; Wang K; Li J; Huang R; Can D; Xu H; Bu G; Chen XF
Mol Neurodegener; 2018 Mar; 13(1):15. PubMed ID: 29587871
[TBL] [Abstract][Full Text] [Related]
20. Soluble TREM2 inhibits secondary nucleation of Aβ fibrillization and enhances cellular uptake of fibrillar Aβ.
Belsare KD; Wu H; Mondal D; Bond A; Castillo E; Jin J; Jo H; Roush AE; Pilla KB; Sali A; Condello C; DeGrado WF
Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35082148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
